Methyl butetisalicylate

Lysine-specific histone demethylase 1A (UniProt Q6ZQ88 also known as BRAF35-HDAC complex protein BHC110, Flavin-containing amine oxidase domain-containing protein 2) is encoded by the Kdm1a (also known as Aof2, Kiaa0601, Lsd1) gene (Gene ID 99982)

General description Protein phosphatase methylesterase 1 (UniProt: Q8BVQ5: also known as PME1: EC:3.1.

General description Huntington disease (HD) is a neurodegenerative disorder caused by an expansion of a polyglutamine (PolyQ) domain in the protein huntingtin (htt) that leads to its aggregation into fibrils. PolyQ expansion above 35 -40 results

General description Huntington disease (HD) is a neurodegenerative disorder caused by an expansion of a polyglutamine (PolyQ) domain in the protein huntingtin (htt) that leads to its aggregation into fibrils. PolyQ expansion above 35 -40 results

Specificity Protein Phosphatase Methylesterase-1 Immunogen A mixture of two nickel agarose-purified, His6-tagged, bacterial expressed human Protein Phosphatase Methylesterase-1 (PME-1) fragments (residues 225-302 and 277-387). These two

An inhibitor of FAAH attenuating the FAAH activity from mouse neuroblastoma cells with an IC₅₀ value of 12 &microM alters both the Km and the Vmax of FAAH, indicating that it is a very tight binding, competitive inhibitor does not

An inhibitor of FAAH attenuating the FAAH activity from mouse neuroblastoma cells with an IC₅₀ value of 12 &microM alters both the Km and the Vmax of FAAH, indicating that it is a very tight binding, competitive inhibitor does not

An inhibitor of FAAH attenuating the FAAH activity from mouse neuroblastoma cells with an IC₅₀ value of 12 &microM alters both the Km and the Vmax of FAAH, indicating that it is a very tight binding, competitive inhibitor does not

AS2717638 is an oral active and selective lysophosphatidic acid receptor 5 (LPA5) antagonist, with an IC50 of 38 nM for hLPA5. AS2717638 also significantly improves PGE2-, PGF2α-, and AMPA-induced allodynia.

AS2717638 is an oral active and selective lysophosphatidic acid receptor 5 (LPA5) antagonist, with an IC50 of 38 nM for hLPA5. AS2717638 also significantly improves PGE2-, PGF2α-, and AMPA-induced allodynia.

AS2717638 is an oral active and selective lysophosphatidic acid receptor 5 (LPA5) antagonist, with an IC50 of 38 nM for hLPA5. AS2717638 also significantly improves PGE2-, PGF2α-, and AMPA-induced allodynia.

AS2717638 is an oral active and selective lysophosphatidic acid receptor 5 (LPA5) antagonist, with an IC50 of 38 nM for hLPA5. AS2717638 also significantly improves PGE2-, PGF2α-, and AMPA-induced allodynia.